Background Hirschsprung disease (HD) is defined by the absence of ganglion cells in the distal bowel, extending proximally from the rectum for a variable length. Most children have rectosigmoid disease, but long-segment (LSHD) and total colonic disease (TCHD) need different surgical planning and have a worse prognosis. Hypertrophic submucosal nerve trunks are a recognised supportive feature on rectal biopsy. Some studies have suggested that their absence may indicate extended aganglionosis, but the evidence is conflicting. It also comes from high-income settings, where children are biopsied as neonates and nerves are measured. No data are available from sub-Saharan Africa. There, diagnosis is often delayed, full-thickness biopsies are common, and nerve hypertrophy is reported qualitatively on haematoxylin and eosin (H&E) alone. Aim To determine whether the absence of hypertrophic nerves on the diagnostic rectal biopsy is associated with the extent of aganglionosis in children with HD. A second aim was to assess the influence of age at biopsy and biopsy type. Methods We performed a retrospective cohort study of all children with HD recorded in the REDCap database of a tertiary paediatric surgical unit in Johannesburg, South Africa. Histology was reported by the National Health Laboratory Service. Children were included if both the diagnostic biopsy and the pull-through (PT) histology reports were available. Nerve status was coded from routine reports as present, absent or not reported, using a predefined protocol. The extent of aganglionosis was determined from the PT specimen together with stoma and levelling biopsies (APSA 2021 classification). Extended disease was defined as LSHD or TCHD. Associations were tested with Fisher’s exact test and odds ratios (OR). We also calculated sensitivity, specificity and predictive values, and fitted an exploratory logistic regression model. Sensitivity analyses reclassified reports with equivocal wording. Reporting followed the STROBE guidelines. Results Of 114 children screened, 69 were included, and 67 had nerve status reported on the diagnostic biopsy. In the 69 included children: • Median age at biopsy was 3.0 months (IQR 1.0–27.0). • 33.3% had a delayed diagnosis (>12 months). • 39.1% had a full-thickness biopsy. • Seven had extended disease (3 LSHD, 4 TCHD). Hypertrophic nerves were absent in 1 of 6 children with extended disease and in 17 of 61 with short-segment disease (OR 0.69, 95% CI 0.10–4.58; p = 1.00). As a predictor of extended disease, absent nerves had: sensitivity 16.7%; specificity 72.1%; positive predictive value 5.6%; negative predictive value 89.8%. The results did not change in the sensitivity analyses. Age at biopsy, biopsy type and delayed diagnosis were not associated with nerve status. Hypertrophic nerves were present in the PT specimen but absent on the diagnostic biopsy in 17 of 56 children (30.4%). This discordance was lower when the suction biopsy was taken in the first month of life (19.0% vs 50.0%). In six children, nerves were present in distal but absent in more proximal aganglionic bowel. Conclusion In our cohort, the absence of hypertrophic nerves on the diagnostic rectal biopsy, as reported qualitatively, was not associated with extended aganglionosis. Hypertrophic nerves remain a useful supportive diagnostic feature, but they should not be used to predict the extent of disease or to plan surgery. The extent should still be determined with intraoperative levelling biopsies. A simple calibrated measurement of nerve diameter, structured reporting and, in the future, artificial intelligence tools could make nerve assessment reproducible. A prospective multicentre study is needed to define their role.

Background Hirschsprung disease (HD) is defined by the absence of ganglion cells in the distal bowel, extending proximally from the rectum for a variable length. Most children have rectosigmoid disease, but long-segment (LSHD) and total colonic disease (TCHD) need different surgical planning and have a worse prognosis. Hypertrophic submucosal nerve trunks are a recognised supportive feature on rectal biopsy. Some studies have suggested that their absence may indicate extended aganglionosis, but the evidence is conflicting. It also comes from high-income settings, where children are biopsied as neonates and nerves are measured. No data are available from sub-Saharan Africa. There, diagnosis is often delayed, full-thickness biopsies are common, and nerve hypertrophy is reported qualitatively on haematoxylin and eosin (H&E) alone. Aim To determine whether the absence of hypertrophic nerves on the diagnostic rectal biopsy is associated with the extent of aganglionosis in children with HD. A second aim was to assess the influence of age at biopsy and biopsy type. Methods We performed a retrospective cohort study of all children with HD recorded in the REDCap database of a tertiary paediatric surgical unit in Johannesburg, South Africa. Histology was reported by the National Health Laboratory Service. Children were included if both the diagnostic biopsy and the pull-through (PT) histology reports were available. Nerve status was coded from routine reports as present, absent or not reported, using a predefined protocol. The extent of aganglionosis was determined from the PT specimen together with stoma and levelling biopsies (APSA 2021 classification). Extended disease was defined as LSHD or TCHD. Associations were tested with Fisher’s exact test and odds ratios (OR). We also calculated sensitivity, specificity and predictive values, and fitted an exploratory logistic regression model. Sensitivity analyses reclassified reports with equivocal wording. Reporting followed the STROBE guidelines. Results Of 114 children screened, 69 were included, and 67 had nerve status reported on the diagnostic biopsy. In the 69 included children: • Median age at biopsy was 3.0 months (IQR 1.0–27.0). • 33.3% had a delayed diagnosis (>12 months). • 39.1% had a full-thickness biopsy. • Seven had extended disease (3 LSHD, 4 TCHD). Hypertrophic nerves were absent in 1 of 6 children with extended disease and in 17 of 61 with short-segment disease (OR 0.69, 95% CI 0.10–4.58; p = 1.00). As a predictor of extended disease, absent nerves had: sensitivity 16.7%; specificity 72.1%; positive predictive value 5.6%; negative predictive value 89.8%. The results did not change in the sensitivity analyses. Age at biopsy, biopsy type and delayed diagnosis were not associated with nerve status. Hypertrophic nerves were present in the PT specimen but absent on the diagnostic biopsy in 17 of 56 children (30.4%). This discordance was lower when the suction biopsy was taken in the first month of life (19.0% vs 50.0%). In six children, nerves were present in distal but absent in more proximal aganglionic bowel. Conclusion In our cohort, the absence of hypertrophic nerves on the diagnostic rectal biopsy, as reported qualitatively, was not associated with extended aganglionosis. Hypertrophic nerves remain a useful supportive diagnostic feature, but they should not be used to predict the extent of disease or to plan surgery. The extent should still be determined with intraoperative levelling biopsies. A simple calibrated measurement of nerve diameter, structured reporting and, in the future, artificial intelligence tools could make nerve assessment reproducible. A prospective multicentre study is needed to define their role.

Hypertrophic nerve trunk on rectal biopsy in Hirschsprung Disease: association with the extent of aganglionosis and age at diagnosis in a South African cohort

CAMPILONGO, CARMEN
2024/2025

Abstract

Background Hirschsprung disease (HD) is defined by the absence of ganglion cells in the distal bowel, extending proximally from the rectum for a variable length. Most children have rectosigmoid disease, but long-segment (LSHD) and total colonic disease (TCHD) need different surgical planning and have a worse prognosis. Hypertrophic submucosal nerve trunks are a recognised supportive feature on rectal biopsy. Some studies have suggested that their absence may indicate extended aganglionosis, but the evidence is conflicting. It also comes from high-income settings, where children are biopsied as neonates and nerves are measured. No data are available from sub-Saharan Africa. There, diagnosis is often delayed, full-thickness biopsies are common, and nerve hypertrophy is reported qualitatively on haematoxylin and eosin (H&E) alone. Aim To determine whether the absence of hypertrophic nerves on the diagnostic rectal biopsy is associated with the extent of aganglionosis in children with HD. A second aim was to assess the influence of age at biopsy and biopsy type. Methods We performed a retrospective cohort study of all children with HD recorded in the REDCap database of a tertiary paediatric surgical unit in Johannesburg, South Africa. Histology was reported by the National Health Laboratory Service. Children were included if both the diagnostic biopsy and the pull-through (PT) histology reports were available. Nerve status was coded from routine reports as present, absent or not reported, using a predefined protocol. The extent of aganglionosis was determined from the PT specimen together with stoma and levelling biopsies (APSA 2021 classification). Extended disease was defined as LSHD or TCHD. Associations were tested with Fisher’s exact test and odds ratios (OR). We also calculated sensitivity, specificity and predictive values, and fitted an exploratory logistic regression model. Sensitivity analyses reclassified reports with equivocal wording. Reporting followed the STROBE guidelines. Results Of 114 children screened, 69 were included, and 67 had nerve status reported on the diagnostic biopsy. In the 69 included children: • Median age at biopsy was 3.0 months (IQR 1.0–27.0). • 33.3% had a delayed diagnosis (>12 months). • 39.1% had a full-thickness biopsy. • Seven had extended disease (3 LSHD, 4 TCHD). Hypertrophic nerves were absent in 1 of 6 children with extended disease and in 17 of 61 with short-segment disease (OR 0.69, 95% CI 0.10–4.58; p = 1.00). As a predictor of extended disease, absent nerves had: sensitivity 16.7%; specificity 72.1%; positive predictive value 5.6%; negative predictive value 89.8%. The results did not change in the sensitivity analyses. Age at biopsy, biopsy type and delayed diagnosis were not associated with nerve status. Hypertrophic nerves were present in the PT specimen but absent on the diagnostic biopsy in 17 of 56 children (30.4%). This discordance was lower when the suction biopsy was taken in the first month of life (19.0% vs 50.0%). In six children, nerves were present in distal but absent in more proximal aganglionic bowel. Conclusion In our cohort, the absence of hypertrophic nerves on the diagnostic rectal biopsy, as reported qualitatively, was not associated with extended aganglionosis. Hypertrophic nerves remain a useful supportive diagnostic feature, but they should not be used to predict the extent of disease or to plan surgery. The extent should still be determined with intraoperative levelling biopsies. A simple calibrated measurement of nerve diameter, structured reporting and, in the future, artificial intelligence tools could make nerve assessment reproducible. A prospective multicentre study is needed to define their role.
2024
Hypertrophic nerves on rectal biopsy in Hirschsprung disease: correlation with the extent of aganglionosis and patient age
Background Hirschsprung disease (HD) is defined by the absence of ganglion cells in the distal bowel, extending proximally from the rectum for a variable length. Most children have rectosigmoid disease, but long-segment (LSHD) and total colonic disease (TCHD) need different surgical planning and have a worse prognosis. Hypertrophic submucosal nerve trunks are a recognised supportive feature on rectal biopsy. Some studies have suggested that their absence may indicate extended aganglionosis, but the evidence is conflicting. It also comes from high-income settings, where children are biopsied as neonates and nerves are measured. No data are available from sub-Saharan Africa. There, diagnosis is often delayed, full-thickness biopsies are common, and nerve hypertrophy is reported qualitatively on haematoxylin and eosin (H&E) alone. Aim To determine whether the absence of hypertrophic nerves on the diagnostic rectal biopsy is associated with the extent of aganglionosis in children with HD. A second aim was to assess the influence of age at biopsy and biopsy type. Methods We performed a retrospective cohort study of all children with HD recorded in the REDCap database of a tertiary paediatric surgical unit in Johannesburg, South Africa. Histology was reported by the National Health Laboratory Service. Children were included if both the diagnostic biopsy and the pull-through (PT) histology reports were available. Nerve status was coded from routine reports as present, absent or not reported, using a predefined protocol. The extent of aganglionosis was determined from the PT specimen together with stoma and levelling biopsies (APSA 2021 classification). Extended disease was defined as LSHD or TCHD. Associations were tested with Fisher’s exact test and odds ratios (OR). We also calculated sensitivity, specificity and predictive values, and fitted an exploratory logistic regression model. Sensitivity analyses reclassified reports with equivocal wording. Reporting followed the STROBE guidelines. Results Of 114 children screened, 69 were included, and 67 had nerve status reported on the diagnostic biopsy. In the 69 included children: • Median age at biopsy was 3.0 months (IQR 1.0–27.0). • 33.3% had a delayed diagnosis (>12 months). • 39.1% had a full-thickness biopsy. • Seven had extended disease (3 LSHD, 4 TCHD). Hypertrophic nerves were absent in 1 of 6 children with extended disease and in 17 of 61 with short-segment disease (OR 0.69, 95% CI 0.10–4.58; p = 1.00). As a predictor of extended disease, absent nerves had: sensitivity 16.7%; specificity 72.1%; positive predictive value 5.6%; negative predictive value 89.8%. The results did not change in the sensitivity analyses. Age at biopsy, biopsy type and delayed diagnosis were not associated with nerve status. Hypertrophic nerves were present in the PT specimen but absent on the diagnostic biopsy in 17 of 56 children (30.4%). This discordance was lower when the suction biopsy was taken in the first month of life (19.0% vs 50.0%). In six children, nerves were present in distal but absent in more proximal aganglionic bowel. Conclusion In our cohort, the absence of hypertrophic nerves on the diagnostic rectal biopsy, as reported qualitatively, was not associated with extended aganglionosis. Hypertrophic nerves remain a useful supportive diagnostic feature, but they should not be used to predict the extent of disease or to plan surgery. The extent should still be determined with intraoperative levelling biopsies. A simple calibrated measurement of nerve diameter, structured reporting and, in the future, artificial intelligence tools could make nerve assessment reproducible. A prospective multicentre study is needed to define their role.
Hirschsprung disease
Hypertrophic nerves
Rectal biopsy
Aganglionosis
Histology
File in questo prodotto:
File Dimensione Formato  
Campilongo_Carmen.pdf

Accesso riservato

Dimensione 12.41 MB
Formato Adobe PDF
12.41 MB Adobe PDF

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/119979